Sign inJoin waitlistJoin the waitlist

Guang-Shing Cheng

Professor, Clinical Research Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Institute for Environmental Medicine
2008–2009
Pulmonary Disease and Critical Care Medicine
Yale Univ Sch of Med
2005–2008
Yale-New Haven Hospital
2003–2004
Yale Univ Sch of Med
2001–2003
University of California, San Francisco School of Medicine
1997–2001
Biology, Harvard University
1990–1994

Research

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group…
Biology of Blood and Marrow Transplantation · 2015 · 2,533 citations
Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts
Annals of Internal Medicine · 2020 · 232 citations
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
Cancer · 2017 · 212 citations

Michael Boeckh
18 papers
Ajay Sheshadri
12 papers
Stephanie Lee
12 papers
Paul Martin
11 papers
Steven Pergam
11 papers
Joshua Hill
10 papers
Kirsten Williams
9 papers
Mary Flowers
9 papers
GY
Gregory Yanik
8 papers
Husham Sharifi
7 papers
Alpana Waghmare
6 papers
Catherine Liu
6 papers

Grants

Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.8M · Fred Hutchinson Cancer Center
2021–2026

Clinical trials

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)
Principal investigator · Active not recruiting
Fred Hutchinson Cancer Center
2022–2028
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Site PI · Recruiting · Phase 2
Dana-Farber Cancer Institute
2024–2027
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Site PI · Recruiting
University of Michigan Rogel Cancer Center
2023–2028